APA
XFOR icon

American Portfolios Advisors’s X4 Pharmaceuticals XFOR Stock Holding History

American Portfolios Advisors’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10.7K Hold
208
– – ﹤0.01% 2510
2022
Q2 		$6.03K Hold
208
– – ﹤0.01% 2759
2022
Q1 		$10.9K Hold
208
– – ﹤0.01% 2651
2021
Q4 		$14.3K Hold
208
– – ﹤0.01% 2477
2021
Q3 		$33.1K Buy
+208
New +$34.2K ﹤0.01% 2005

Other funds holding XFOR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

American Portfolios Advisors's XFOR Position: Q3 2022 in Review

American Portfolios Advisors held its X4 Pharmaceuticals (XFOR) position steady in Q3 2022 at 208 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2510.

American Portfolios Advisors first reported a position in XFOR in Q3 2021 and has held it in 5 quarters since. The position peaked at $33.1K in Q3 2021. 56 funds tracked by Wall St. Rank hold XFOR as of Q3 2022.

  • American Portfolios Advisors held 208 shares of X4 Pharmaceuticals worth $10.7K as of Q3 2022.
  • American Portfolios Advisors left its X4 Pharmaceuticals share count unchanged in Q3 2022.
  • X4 Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2510 holding.
  • American Portfolios Advisors first reported a position in X4 Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
  • American Portfolios Advisors's X4 Pharmaceuticals position peaked at $33.1K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.